SANUWAVE HEALTH INC (SNWV) Fundamental Analysis & Valuation

NASDAQ:SNWV • US80303D3052

Current stock price

15.73 USD
-0.64 (-3.91%)
At close:
15.73 USD
0 (0%)
After Hours:

This SNWV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SNWV Profitability Analysis

1.1 Basic Checks

  • SNWV had negative earnings in the past year.
  • In the past year SNWV had a positive cash flow from operations.
  • In the past 5 years SNWV reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: SNWV reported negative operating cash flow in multiple years.
SNWV Yearly Net Income VS EBIT VS OCF VS FCFSNWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M

1.2 Ratios

  • SNWV has a better Return On Assets (31.63%) than 99.47% of its industry peers.
  • SNWV has a better Return On Equity (729.65%) than 100.00% of its industry peers.
  • SNWV has a better Return On Invested Capital (20.04%) than 97.33% of its industry peers.
Industry RankSector Rank
ROA 31.63%
ROE 729.65%
ROIC 20.04%
ROA(3y)-62.55%
ROA(5y)-77.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNWV Yearly ROA, ROE, ROICSNWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • Looking at the Profit Margin, with a value of 26.82%, SNWV belongs to the top of the industry, outperforming 96.26% of the companies in the same industry.
  • SNWV has a better Operating Margin (11.23%) than 80.21% of its industry peers.
  • SNWV's Gross Margin of 77.11% is amongst the best of the industry. SNWV outperforms 87.70% of its industry peers.
  • SNWV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.23%
PM (TTM) 26.82%
GM 77.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.32%
GM growth 5Y1.56%
SNWV Yearly Profit, Operating, Gross MarginsSNWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SNWV Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNWV is creating value.
  • SNWV has more shares outstanding than it did 1 year ago.
  • SNWV has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SNWV has been reduced compared to a year ago.
SNWV Yearly Shares OutstandingSNWV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
SNWV Yearly Total Debt VS Total AssetsSNWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -4.99, we must say that SNWV is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -4.99, SNWV is not doing good in the industry: 72.19% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of SNWV is 11.35, which is on the high side as it means it would take SNWV, 11.35 years of fcf income to pay off all of its debts.
  • SNWV's Debt to FCF ratio of 11.35 is fine compared to the rest of the industry. SNWV outperforms 70.59% of its industry peers.
  • A Debt/Equity ratio of 10.08 is on the high side and indicates that SNWV has dependencies on debt financing.
  • SNWV has a Debt to Equity ratio of 10.08. This is amonst the worse of the industry: SNWV underperforms 90.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.08
Debt/FCF 11.35
Altman-Z -4.99
ROIC/WACC2.1
WACC9.55%
SNWV Yearly LT Debt VS Equity VS FCFSNWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M -40M

2.3 Liquidity

  • SNWV has a Current Ratio of 1.38. This is a normal value and indicates that SNWV is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SNWV (1.38) is worse than 81.28% of its industry peers.
  • SNWV has a Quick Ratio of 1.05. This is a normal value and indicates that SNWV is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.05, SNWV is doing worse than 80.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.05
SNWV Yearly Current Assets VS Current LiabilitesSNWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. SNWV Growth Analysis

3.1 Past

  • SNWV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.67%, which is quite impressive.
  • Looking at the last year, SNWV shows a very strong growth in Revenue. The Revenue has grown by 34.98%.
  • The Revenue has been growing slightly by 3.96% on average over the past years.
EPS 1Y (TTM)116.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%173.55%
Revenue 1Y (TTM)34.98%
Revenue growth 3Y-9.23%
Revenue growth 5Y3.96%
Sales Q2Q%26.76%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year228.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SNWV Yearly Revenue VS EstimatesSNWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SNWV Yearly EPS VS EstimatesSNWV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2025 2026 2027 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

2

4. SNWV Valuation Analysis

4.1 Price/Earnings Ratio

  • SNWV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SNWV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNWV Price Earnings VS Forward Price EarningsSNWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SNWV is valued a bit cheaper than 71.66% of the companies in the same industry.
  • SNWV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SNWV is cheaper than 70.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 69.87
EV/EBITDA 24.52
SNWV Per share dataSNWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

  • SNWV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SNWV Dividend Analysis

5.1 Amount

  • No dividends for SNWV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SNWV Fundamentals: All Metrics, Ratios and Statistics

SANUWAVE HEALTH INC

NASDAQ:SNWV (5/1/2026, 8:00:02 PM)

After market: 15.73 0 (0%)

15.73

-0.64 (-3.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.01
Earnings (Last)04-16
Earnings (Next)08-06
Inst Owners56.24%
Inst Owner Change-0.57%
Ins Owners1.33%
Ins Owner Change-0.86%
Market Cap135.12M
Revenue(TTM)44.05M
Net Income(TTM)11.81M
Analysts82.5
Price Target44.37 (182.07%)
Short Float %7.91%
Short Ratio9.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)193.63%
Min EPS beat(2)-26.01%
Max EPS beat(2)413.26%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)-1.78%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-19.44%
PT rev (3m)-19.44%
EPS NQ rev (1m)-37.31%
EPS NQ rev (3m)-157.5%
EPS NY rev (1m)-57.11%
EPS NY rev (3m)-57.11%
Revenue NQ rev (1m)-2.04%
Revenue NQ rev (3m)-13.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.07
P/FCF 69.87
P/OCF 34.86
P/B 83.46
P/tB N/A
EV/EBITDA 24.52
EPS(TTM)-18.75
EYN/A
EPS(NY)-19.12
Fwd EYN/A
FCF(TTM)0.23
FCFY1.43%
OCF(TTM)0.45
OCFY2.87%
SpS5.13
BVpS0.19
TBVpS-1.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 31.63%
ROE 729.65%
ROCE 25.36%
ROIC 20.04%
ROICexc 51.83%
ROICexgc N/A
OM 11.23%
PM (TTM) 26.82%
GM 77.11%
FCFM 4.39%
ROA(3y)-62.55%
ROA(5y)-77.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.32%
GM growth 5Y1.56%
F-Score6
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 10.08
Debt/FCF 11.35
Debt/EBITDA 2.76
Cap/Depr 199.38%
Cap/Sales 4.41%
Interest Coverage 1.32
Cash Conversion 65.48%
Profit Quality 16.37%
Current Ratio 1.38
Quick Ratio 1.05
Altman-Z -4.99
F-Score6
WACC9.55%
ROIC/WACC2.1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%173.55%
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.98%
Revenue growth 3Y-9.23%
Revenue growth 5Y3.96%
Sales Q2Q%26.76%
Revenue Next Year228.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.88%
OCF growth 3YN/A
OCF growth 5YN/A

SANUWAVE HEALTH INC / SNWV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SANUWAVE HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to SNWV.


Can you provide the valuation status for SANUWAVE HEALTH INC?

ChartMill assigns a valuation rating of 2 / 10 to SANUWAVE HEALTH INC (SNWV). This can be considered as Overvalued.


How profitable is SANUWAVE HEALTH INC (SNWV) stock?

SANUWAVE HEALTH INC (SNWV) has a profitability rating of 6 / 10.